Meropenem-Associated Acute Hepatocellular Liver Injury: A Rare Case Report
Küçük Resim Yok
Tarih
2026
Dergi Başlığı
Dergi ISSN
Cilt Başlığı
Yayıncı
Bilimsel Tip Yayinevi
Erişim Hakkı
info:eu-repo/semantics/openAccess
Özet
Drug-induced liver injury (DILI) is a serious and commonly encountered clinical complication, the diagnosis of which is usually established by exclusion. Antibiotics, particularly beta-lactam agents, are among the leading causes of DILI. Meropenem is a widely used broad-spectrum carbapenem antibiotic. This report presents a case of acute hepatocellular liver injury that developed within 24 hours after initiation of meropenem for the treatment of pneumonia in an 85-year-old patient. Viral hepatitis, autoimmune diseases, and other potential causes of liver injury were comprehensively excluded. In the presence of marked elevations in liver enzymes, meropenem was discontinued, after which the biochemical abnormalities were observed to resolve spontaneously without any specific treatment. Reports of meropenem-induced liver injury are rare in the literature; the rapid onset and reversibility observed in this case underscore the importance of drug discontinuation in management. In clinical practice, awareness of the risk of hepatotoxicity associated with meropenem use and adoption of a multidisciplinary approach in similar cases are of great importance.
Açıklama
Anahtar Kelimeler
Drug-induced liver injury, Hepatotoxicity, Meropenem
Kaynak
Flora Infeksiyon Hastaliklari Ve Klinik Mikrobiyoloji Dergisi
WoS Q Değeri
Q4
Scopus Q Değeri
Cilt
31
Sayı
1
